Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte–specific expression in vivo

The α1(X) collagen gene (Col10a1) is the only known hypertrophic chondrocyte–specific molecular marker. Until recently, few transcriptional factors specifying its tissue-specific expression have been identified. We show here that a 4-kb murine Col10a1 promoter can drive β-galactosidase expression in lower hypertrophic chondrocytes in transgenic mice. Comparative genomic analysis revealed multiple Runx2 (Runt domain transcription factor) binding sites within the proximal human, mouse, and chick Col10a1 promoters. In vitro transfection studies and chromatin immunoprecipitation analysis using hypertrophic MCT cells showed that Runx2 contributes to the transactivation of this promoter via its conserved Runx2 binding sites. When the 4-kb Col10a1 promoter transgene was bred onto a Runx2 +/− background, the reporter was expressed at lower levels. Moreover, decreased Col10a1 expression and altered chondrocyte hypertrophy was also observed in Runx2 heterozygote mice, whereas Col10a1 was barely detectable in Runx2-null mice. Together, these data suggest that Col10a1 is a direct transcriptional target of Runx2 during chondrogenesis.

[1]  R. Savarirayan,et al.  Tissue-specific RNA surveillance? Nonsense-mediated mRNA decay causes collagen X haploinsufficiency in Schmid metaphyseal chondrodysplasia cartilage. , 2003, Human molecular genetics.

[2]  J. Bateman,et al.  Collagen X Chains Harboring Schmid Metaphyseal Chondrodysplasia NC1 Domain Mutations Are Selectively Retained and Degraded in Stably Transfected Cells* , 2002, The Journal of Biological Chemistry.

[3]  P. Farnham,et al.  Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. , 2002, Methods.

[4]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[5]  Brendan H. Lee,et al.  A natural history of cleidocranial dysplasia. , 2001, American journal of medical genetics.

[6]  I. Ho,et al.  A quantitative histochemistry technique for measuring regional distribution of acetylcholinesterase in the brain using digital scanning densitometry. , 2001, Analytical biochemistry.

[7]  C. Hartmann,et al.  Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2 , 2001, Mechanisms of Development.

[8]  W. C. Forrester,et al.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. , 2001, Molecular cell.

[9]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[10]  N. Kanatani,et al.  Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.

[11]  D. Chan,et al.  Aberrant Signal Peptide Cleavage of Collagen X in Schmid Metaphyseal Chondrodysplasia , 2001, The Journal of Biological Chemistry.

[12]  G. Stein,et al.  Smad-Runx Interactions During Chondrocyte Maturation , 2001, The Journal of bone and joint surgery. American volume.

[13]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[14]  A. McMahon,et al.  Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. , 2001, The Journal of clinical investigation.

[15]  C. Bendixen,et al.  Abnormal growth plate function in pigs carrying a dominant mutation in type X collagen , 2000, Mammalian Genome.

[16]  B. Zabel,et al.  Equal expression of type X collagen mRNA from mutant and wild typeCOL10A1 alleles in growth plate cartilage from a patient with metaphyseal chondrodysplasia type Schmid , 2000, Journal of medical genetics.

[17]  O. Jacenko,et al.  Growth Plate Compressions and Altered Hematopoiesis in Collagen X Null Mice , 2000, The Journal of cell biology.

[18]  Y. Kitamura,et al.  Cbfa1 Is a Positive Regulatory Factor in Chondrocyte Maturation* , 2000, The Journal of Biological Chemistry.

[19]  P. Farnham,et al.  Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells , 1999, Molecular and Cellular Biology.

[20]  Lei Zhou,et al.  CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. , 1999, Human molecular genetics.

[21]  A. McMahon,et al.  Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. , 1999, Genes & development.

[22]  C. López-Otín,et al.  Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation , 1999, Molecular and Cellular Biology.

[23]  S. Nomura,et al.  Maturational disturbance of chondrocytes in Cbfa1‐deficient mice , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  D. Marks,et al.  Metaphyseal Chondrodysplasia Type Schmid Mutations Are Predicted to Occur in Two Distinct Three-dimensional Clusters within Type X Collagen NC1 Domains That Retain the Ability to Trimerize* , 1999, The Journal of Biological Chemistry.

[25]  S. Mundlos,et al.  Regulation of chondrocyte differentiation by Cbfa1 , 1999, Mechanisms of Development.

[26]  Takahiro Ochi,et al.  Transcriptional regulation of osteopontin gene in vivo by PEBP2αA/CBFA1 and ETS1 in the skeletal tissues , 1998, Oncogene.

[27]  P. LuValle,et al.  Proximal DNA elements mediate repressor activity conferred by the distal portion of the chicken collagen X promoter , 1998, Journal of cellular biochemistry.

[28]  D. Chan,et al.  Phenotypic and biochemical consequences of collagen X mutations in mice and humans. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[29]  B. Lanske,et al.  Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Gregor Eichele,et al.  Studying gene expression on tissue sections using in situ hybridization. , 1997 .

[31]  K. von der Mark,et al.  Localization of silencer and enhancer elements in the human type X collagen gene , 1997, Journal of cellular biochemistry.

[32]  A. Baldini,et al.  Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia , 1997, Nature Genetics.

[33]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[34]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[35]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[36]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[37]  Patrick P.L. Tam,et al.  Abnormal Compartmentalization of Cartilage Matrix Components in Mice Lacking Collagen X: Implications for Function , 1997, The Journal of cell biology.

[38]  B. Lanske,et al.  PTH/PTHrP Receptor in Early Development and Indian Hedgehog--Regulated Bone Growth , 1996, Science.

[39]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[40]  F. Poudevigne,et al.  Isolation and Identification of Bacteria Associated with the Screwworm Fly Cochliomyia hominivorax, Coquerel and Its Myiasis a , 1996, Annals of the New York Academy of Sciences.

[41]  E. Vuorio,et al.  Tissue Distribution and Phenotypic Consequences of Different Type X Collagen Gene Constructs in Transgenic Mice , 1996, Annals of the New York Academy of Sciences.

[42]  S. Mundlos,et al.  Cleidocranial Dysplasia in Mice , 1996, Annals of the New York Academy of Sciences.

[43]  M. Lammi,et al.  Transcriptional Regulation of the Human Type X Collagen Gene Expression , 1996, Annals of the New York Academy of Sciences.

[44]  V. Lefebvre,et al.  A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. , 1995, Journal of cell science.

[45]  H. Jüppner,et al.  A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. , 1995, Science.

[46]  V. Lefebvre,et al.  Type X collagen gene expression in mouse chondrocytes immortalized by a temperature-sensitive simian virus 40 large tumor antigen , 1995, The Journal of cell biology.

[47]  R. Behringer,et al.  Normal long bone growth and development in type X collagen-null mice , 1994, Nature Genetics.

[48]  J Glowacki,et al.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. , 1994, Genes & development.

[49]  B. Olsen,et al.  Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition , 1993, Nature.

[50]  B. Olsen,et al.  A type X collagen mutation causes Schmid metaphyseal chondrodysplasia , 1993, Nature Genetics.

[51]  C. Houston,et al.  Metaphyseal chondrodysplasia, Schmid type. A defect of ultrastructural metabolism: case report. , 1980, The Journal of bone and joint surgery. American volume.

[52]  K. von der Mark,et al.  Role of c‐fos in the regulation of type X collagen gene expression by PTH and PTHrP: Localization of a PTH/PTHrP‐responsive region in the human COL10A1 enhancer , 2002, Journal of cellular biochemistry.

[53]  Kenneth W. Adolph,et al.  Human genome methods , 1998 .

[54]  S. Mundlos,et al.  Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. , 1995, Human molecular genetics.

[55]  R. B. Dyer,et al.  Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. , 1995, BioTechniques.

[56]  M. Ashburner A Laboratory manual , 1989 .

[57]  K. Kozlowski,et al.  Spondylometaphyseal dysplasia. , 1973, The British journal of radiology.